Clinical Trials Update: April 20 2005
Prostatic Intraepithelial Neoplasia Parkinson's Disease Chronic Bronchitis
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Prostatic Intraepithelial Neoplasia
This is a randomized, double-blind, placebo-controlled research study to determine if toremifene citrate (an investigational drug) is effective and safe for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia. Research sites located throughout the United States.
This study will evaluate participants' eyesight and ability to see different lights and colors while taking Parkinson's disease medications. You may qualify if you have had Parkinson's for less than seven years, and are 30 years of age or older. Research site located in New York, NY.
You may be eligible for this study if you currently have a lower respiratory tract infection. Research site located in Portage, Mich.
Copyright 2005 CenterWatch. All rights reserved.